Showing results (2211-2220 of 9,152) with videos related to
Sort By:
Pageof 916
Cancer Medicine|June 20, 2023
Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factorsHao-Wen Wei, Shui-Ling Qin, Jing-Xuan Xu, et al.Cancer Medicine|June 21, 2023
Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinomaYunfeng Li, Chaochao Tan, Xinmin Yin, et al.Cancer Medicine|June 17, 2023
Patient and public involvement in cancer research: A scoping reviewSara Colomer-Lahiguera, Matthieu Steimer, Ursula Ellis, et al.Cancer Medicine|June 16, 2023
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II studyXichao Dai, Leilei Tao, Jinqiu Wang, et al.Cancer Medicine|June 16, 2023
Treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database studyYi-Hsin Liang, Kuo-Hsing Chen, Yu-Yun ShaoCancer Medicine|June 16, 2023
Effects of fear of cancer recurrence on subjective physical and mental health in breast cancer patients: The intermediary role of heart rate variabilityQianqian Zhang, Yinlian Cai, Sheng Yu, et al.Cancer Medicine|June 16, 2023
Innovations in healthcare delivery: Human papilloma virus self sampling diagnostics and participatory innovations for CCSEvans Appiah OseiCancer Medicine|June 15, 2023
Impact of pre- and post-diagnosis physical activity on the mortality of patients with cancer: Results from the Health Examinees-G study in KoreaJaesung Choi, Joo-Yong Park, Ji-Eun Kim, et al.Cancer Medicine|June 15, 2023
Physical activity maintenance among young adult cancer survivors in an mHealth intervention: Twelve-month outcomes from the IMPACT randomized controlled trialCarmina G Valle, Molly A Diamond, Hillary M Heiling, et al.Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.Pageof 916